Collegium Pharmaceutical, Inc filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-05-12. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
Leadership Changes On May 11, 2026, the Company announced that Scott Dreyer, Executive Vice President and Chief Commercial Officer of the Company will depart from his positions at the Company effective August 30, 2026.
Departing: John Fallon, Director
Director Retirement On April 2, 2026, John Fallon, M.D., a current member of the Board, advised the Board that he will not stand for re-election at the Annual Meeting and will retire from the Board at that time.
Find people with the same kind of experience as the Director at Collegium Pharmaceutical, Inc, with the record behind each one.
Find candidates like Director at Collegium Pharmaceutical, IncNew leaders review vendors and budgets in their first months. Get an alert the next time Collegium Pharmaceutical, Inc is in the news or changes leadership.
Get an alert when Collegium Pharmaceutical, Inc changes leadershipTools for this story
Each opens in a new tab, filled in for Collegium Pharmaceutical, Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.